Citadel Advisors’s Innovator IBD ETF Leaders ETF LDRS Stock Holding History

Citadel Advisors’s Portfolio LDRS Stock Details LDRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-16,820	Closed	-$406K	–	11787
2020 Q3	$406K	Sell	16,820 -2,288	-12%	-$53.2K	﹤0.01%	7642
2020 Q2	$388K	Sell	19,108 -1,587	-8%	-$30.3K	﹤0.01%	7488
2020 Q1	$385K	Buy	20,695 +1,145	+6%	+$24.5K	﹤0.01%	6900
2019 Q4	$440K	Sell	19,550 -9,154	-32%	-$203K	﹤0.01%	7014
2019 Q3	$631K	Sell	28,704 -4,994	-15%	-$109K	﹤0.01%	6355
2019 Q2	$715K	Buy	33,698 +9,971	+42%	+$211K	﹤0.01%	6247
2019 Q1	$507K	Sell	23,727 -35,291	-60%	-$755K	﹤0.01%	6766
2018 Q4	$1.26M	Buy	59,018 +12,266	+26%	+$280K	﹤0.01%	4936
2018 Q3	$1.19M	Buy	46,752 +9,598	+26%	+$244K	﹤0.01%	5251
2018 Q2	$936K	Buy	37,154 +27,523	+286%	+$680K	﹤0.01%	5342
2018 Q1	$237K	Buy	+9,631	New	+$247K	﹤0.01%	7086

Other funds holding LDRS

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors's LDRS Position: Q4 2020 in Review

Citadel Advisors sold out of Innovator IBD ETF Leaders ETF (LDRS) in Q4 2020, closing a stake of 16,820 shares — an estimated $406K sold.

Citadel Advisors first reported a position in LDRS in Q1 2018 and held it in 11 quarters. The position peaked at $1.26M in Q4 2018. 4 funds tracked by Wall St. Rank hold LDRS as of Q4 2020.

Citadel Advisors reported no remaining Innovator IBD ETF Leaders ETF position as of Q4 2020 after selling out during the quarter.
Citadel Advisors sold 16,820 Innovator IBD ETF Leaders ETF shares in Q4 2020, an estimated $406K.
Citadel Advisors first reported a position in Innovator IBD ETF Leaders ETF in Q1 2018 and held it in 11 quarters.
Citadel Advisors's Innovator IBD ETF Leaders ETF position peaked at $1.26M in Q4 2018.
4 funds tracked by Wall St. Rank held Innovator IBD ETF Leaders ETF as of Q4 2020.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.